Overall n |
First Study (n=58) |
Second Study (n=55) |
Males |
26 |
26 |
Females |
32 |
29 |
p-value (d) |
p=0.851 (b) |
Mean age (years) |
43.3 |
49.6 |
Number of respondents |
58 |
54 |
p-value (d) |
p=0.0180 (c) |
Cold Sores per year |
Mean |
4.2 |
4.9 |
Median |
4.0 |
3.0 |
Number of respondents |
58 |
54 |
p-value (a) |
p=0.488 (b) |
|
Untreated Cold Sore Duration – Loss of hard scab |
Mean |
11.1 days |
11.5 days |
Median |
10.0 days |
11.0 days |
Number of respondents |
58 |
54 |
p-value (a) |
p=0.588 (b) |
Viroxyn Time to healing |
Mean |
4.0 |
4.0 |
Median |
3.0 |
4.0 |
Number of respondents |
58 |
55 |
p-value (a) |
p=0.966 (b) |
Untreated Time to loss of discomfort |
Mean |
6.2 days |
6.2 days |
Median |
5.0 days |
6.0 days |
Number of respondents |
57 |
51 |
p-value (a) |
p=0.991 (b) |
Viroxyn Time to loss of discomfort |
Mean |
0.53 days |
0.73 days |
Median |
0.007 days |
0.042 days |
Number of respondents |
58 |
54 |
p-value |
p=0.412 (b) |
P-value Viroxyn v. Control (a) |
<0.001 (c) |
a. Two Tail Independent t-test
b. Confirms the null hypothesis of no difference between studies
c. Statistically significant difference between studies
d. Fishers exact test
|